Trials / Completed
CompletedNCT05864612
Tools for Anxiety and Depression Screening in Epilepsy
Developing Interoperable Tools for Anxiety and Depression Screening in Epilepsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 880 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized trial to compare patient-completion success of REDCap and Electronic Health Record (EHR)-based anxiety \& depression instrument delivery methods. Study hypothesis is that the screening completion proportion will vary across the 4 modalities tested.
Detailed description
In this randomized study of four modalities, we will compare Twilio text message delivery via REDCap versus (vs.) REDCap email survey links vs. EHR portal questionnaires with reminder message vs. current standard delivery EHR portal questionnaires without reminder. Screening instruments will be delivered by randomized method 7 days prior to scheduled clinic visit and outcomes occur by the time of the scheduled clinic visit. The study setting is the Wake Forest Comprehensive Epilepsy Center, with 2 clinic sites where adult patients are served (Atrium Health Wake Forest Baptist main campus, Atrium Health High Point Medical Center). EHR portal questionnaires without reminder is the current standard care screener delivery method. An exploratory supplement randomizing individuals to text message versus email survey link was later added.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Screening Questionnaires | Standard care screening questionnaires on anxiety and depression |
Timeline
- Start date
- 2023-09-20
- Primary completion
- 2024-09-03
- Completion
- 2024-09-03
- First posted
- 2023-05-18
- Last updated
- 2025-10-30
- Results posted
- 2025-10-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05864612. Inclusion in this directory is not an endorsement.